Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
26.87
+0.33 (1.24%)
Nov 22, 2024, 4:00 PM EST - Market closed
Immunovant Market Cap
Immunovant has a market cap or net worth of $3.94 billion as of November 22, 2024. Its market cap has decreased by -19.05% in one year.
Market Cap
3.94B
Enterprise Value
3.47B
1-Year Change
-19.05%
Ranking
Category
Stock Price
$26.87
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $3.94B, an increase of 3,071.14%. That is a compound annual growth rate of 89.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 3.70B | -39.26% |
| Dec 29, 2023 | 6.09B | 165.79% |
| Dec 30, 2022 | 2.29B | 134.03% |
| Dec 31, 2021 | 979.80M | -78.33% |
| Dec 31, 2020 | 4.52B | 404.67% |
| Dec 31, 2019 | 895.95M | 620.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haemonetics | 4.27B |
| Oscar Health | 4.20B |
| ICU Medical | 4.10B |
| Prestige Consumer Healthcare | 4.08B |
| CRISPR Therapeutics AG | 4.03B |
| Organon & Co. | 3.79B |
| Guardant Health | 3.79B |
| Alvotech | 3.75B |